Independent Director 2025 Annual Performance Report (Pan Ying)
To All Shareholders and Shareholder Representatives:
As an independent director of Fulong Jinggong Co., Ltd. (hereinafter referred to as the "Company"), I, in accordance with the "Company Law," "Securities Law," "Administrative Measures for Independent Directors of Listed Companies," "Shenzhen Stock Exchange GEM Stock Listing Rules," "Shenzhen Stock Exchange GEM Listed Company Self-Regulatory Management Guide No. 2—GEM Listed Company Normative Operation," and other relevant laws and regulations, as well as the "Articles of Association" and "Independent Director Work System," have faithfully performed my duties as an independent director, played the role of an independent director, and effectively protected the interests of the Company and all shareholders, especially small and medium shareholders. This report outlines my performance of independent director duties in 2025:
I. Basic Information
I, Pan Ying, am a Chinese national, born in 1973, holding a Master of Laws degree and an associate professor title. My primary research areas are company law, bankruptcy law, and corporate governance. I have been employed at Southwestern University of Finance and Economics since March 2005, and have served as an associate professor there since January 2014. I have served as an independent director of the Company since July 2023. My detailed information can be found in the "Information on Directors and Senior Management" section of the Company's "2025 Annual Report."
During the reporting period, my position met the independence requirements stipulated in Article 6 of the "Administrative Measures for Independent Directors of Listed Companies," and there were no circumstances that affected my independence.
II. Performance of Duties in 2025
(I) Attendance at Board and Shareholder Meetings
In 2025, the Company held a total of 7 board meetings and 3 shareholder meetings. I personally attended all these meetings. With a diligent and responsible attitude, I carefully reviewed the meeting materials, actively participated in the discussion of various proposals, and conscientiously fulfilled my obligations as an independent director by exercising my voting rights. There were no instances of absence, proxy attendance, or failure to attend in person for two consecutive meetings.
In 2025, the convening and holding of the Company's board and shareholder meetings complied with statutory procedures. Major operating decisions and other significant matters underwent the relevant approval procedures and were legal and effective. I carefully reviewed all proposals submitted to the board of directors and concluded that these proposals did not harm the interests of all shareholders, particularly small and medium shareholders. Therefore, I voted in favor of all proposals, with no opposing or abstaining votes.
(II) Attendance at Board Special Committee Meetings
In 2025, I served as the Chairman of the Nomination Committee, a member of the Audit Committee, and a member of the Remuneration and Appraisal Committee of the Company's board of directors. In accordance with the "Articles of Association," "Independent Director Work System," "Nomination Committee Work Rules," "Audit Committee Work Rules," and "Remuneration and Appraisal Committee Work Rules," I conscientiously performed my duties.
-
In 2025, the Nomination Committee did not hold any meetings.
-
In 2025, the Audit Committee held 5 meetings. As a member of the Company's Audit Committee, I participated in all Audit Committee meetings as required, without any unexcused absences. I diligently performed my duties by reviewing matters related to the Company's internal audit, internal control, and periodic reports. I effectively supervised the annual audit work arrangements and progress, listened carefully to reports on the Company's production and operation status and significant developments, and conscientiously fulfilled my responsibilities as a member of the Audit Committee.